Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Anemia

  Free Subscription


Articles published in Ann Hematol

Retrieve available abstracts of 153 articles:
HTML format
Text format



Single Articles


    February 2020
  1. PEFFAULT DE LATOUR R, Huynh L, Ivanova JI, Totev T, et al
    Burden of illness among patients with severe aplastic anemia who have had insufficient response to immunosuppressive therapy: a multicenter retrospective chart review study.
    Ann Hematol. 2020 Feb 17. pii: 10.1007/s00277-019-03809.
    PubMed     Text format     Abstract available


  2. NICOLETTI E, Rao G, Bueren JA, Rio P, et al
    Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization.
    Ann Hematol. 2020 Feb 17. pii: 10.1007/s00277-020-03954.
    PubMed     Text format     Abstract available


    January 2020
  3. RUSSO G, Guardabasso V, Romano F, Corti P, et al
    Monitoring oral iron therapy in children with iron deficiency anemia: an observational, prospective, multicenter study of AIEOP patients (Associazione Italiana Emato-Oncologia Pediatrica).
    Ann Hematol. 2020 Jan 21. pii: 10.1007/s00277-020-03906.
    PubMed     Text format     Abstract available


  4. EL-GAMAL RAE, Abdel-Messih IY, Habashy DM, Zaiema SEG, et al
    Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia.
    Ann Hematol. 2020;99:31-39.
    PubMed     Text format     Abstract available


    December 2019
  5. QIU Y, Cai H, Cui L, Liu YX, et al
    Identification of a novel heterozygous ALAS2 mutation in a young Chinese female with X-linked sideroblastic anemia.
    Ann Hematol. 2019 Dec 17. pii: 10.1007/s00277-019-03894.
    PubMed     Text format    


  6. KAUNDAL R, Bhatia P, Jain A, Jain A, et al
    Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia.
    Ann Hematol. 2019 Dec 6. pii: 10.1007/s00277-019-03871.
    PubMed     Text format     Abstract available


  7. PARK S, Kelaidi C, Meunier M, Casadevall N, et al
    Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion.
    Ann Hematol. 2019 Dec 2. pii: 10.1007/s00277-019-03874.
    PubMed     Text format     Abstract available


  8. LAURENTINO MR, Parente Filho SLA, Parente LLC, da Silva Junior GB, et al
    Non-invasive urinary biomarkers of renal function in sickle cell disease: an overview.
    Ann Hematol. 2019;98:2653-2660.
    PubMed     Text format     Abstract available


  9. YINGJUN X, Yuhuan X, Yuchang C, Dongzhi L, et al
    CRISPR/Cas9 gene correction of HbH-CS thalassemia-induced pluripotent stem cells.
    Ann Hematol. 2019;98:2661-2671.
    PubMed     Text format     Abstract available


    November 2019
  10. LV X, Dong S, Lan F, Zhang B, et al
    Congenital dyserythropoietic anemia type I mimicking myelodysplasia syndrome with a novel CDAN1 mutation.
    Ann Hematol. 2019 Nov 23. pii: 10.1007/s00277-019-03848.
    PubMed     Text format    


  11. SABUNCUOGLU S, Oztas Y, Yalcinkaya A, Unal S, et al
    The increased neopterin content in turkish pediatric patients with sickle cell anemia.
    Ann Hematol. 2019 Nov 23. pii: 10.1007/s00277-019-03817.
    PubMed     Text format     Abstract available


  12. OLATUNYA OS, Lanaro C, Longhini AL, Penteado CFF, et al
    Red blood cells microparticles are associated with hemolysis markers and may contribute to clinical events among sickle cell disease patients.
    Ann Hematol. 2019;98:2507-2521.
    PubMed     Text format     Abstract available


  13. MASY V, Sokal E, Ranguelov N, Brichard B, et al
    Fatal type B lactic acidosis in a patient with end-stage liver disease related to homozygous sickle cell disease.
    Ann Hematol. 2019;98:2627-2628.
    PubMed     Text format    


    October 2019
  14. CHOQUE-QUISPE BM, Paz V, Gonzales GF
    Proportion of anemia attributable to iron deficiency in high-altitude infant populations.
    Ann Hematol. 2019 Oct 30. pii: 10.1007/s00277-019-03823.
    PubMed     Text format    


  15. PARK S, Kelaidi C, Meunier M, Casadevall N, et al
    The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion.
    Ann Hematol. 2019 Oct 25. pii: 10.1007/s00277-019-03799.
    PubMed     Text format     Abstract available


  16. HUSCENOT T, Darnige L, Wagner-Ballon O, Ronchetti AM, et al
    Iron deficiency, an unusual cause of thrombocytopenia: results from a multicenter retrospective case-controlled study.
    Ann Hematol. 2019;98:2299-2302.
    PubMed     Text format     Abstract available


  17. TAKAHASHI T, Ichikawa S, Harigae H
    Successful cord blood transplantation for a paroxysmal nocturnal hemoglobinuria complicated with Budd-Chiari syndrome and myelodysplastic syndrome.
    Ann Hematol. 2019;98:2427-2428.
    PubMed     Text format    


  18. HUANG Y, Liu X, Chen F, Zhou W, et al
    Prediction of thrombosis risk in patients with paroxysmal nocturnal hemoglobinuria.
    Ann Hematol. 2019;98:2283-2291.
    PubMed     Text format     Abstract available


  19. KARIMI M, Haghpanah S, Pishdad P, Zahedi Z, et al
    Frequency of silent brain lesions and aspirin protection evaluation over 3 years follow-up in beta thalassemia patients.
    Ann Hematol. 2019;98:2267-2271.
    PubMed     Text format     Abstract available


  20. KIM JS, Cheong JW, Mun YC, Jang JH, et al
    Clinical implication of renal dysfunction during the clinical course in patients with paroxysmal nocturnal hemoglobinuria: a longitudinal analysis.
    Ann Hematol. 2019;98:2273-2281.
    PubMed     Text format     Abstract available


    September 2019
  21. NICOLAU M, Vargas S, Silva M, Coelho A, et al
    Genetic modulators of fetal hemoglobin expression and ischemic stroke occurrence in African descendant children with sickle cell anemia.
    Ann Hematol. 2019 Sep 2. pii: 10.1007/s00277-019-03783.
    PubMed     Text format     Abstract available


  22. SRINOUN K, Sathirapongsasuti N, Paiboonsukwong K, Sretrirutchai S, et al
    miR-144 regulates oxidative stress tolerance of thalassemic erythroid cell via targeting NRF2.
    Ann Hematol. 2019;98:2045-2052.
    PubMed     Text format     Abstract available


    August 2019
  23. MEHER S, Patel S, Das K, Dehury S, et al
    Association of plasma homocysteine level with vaso-occlusive crisis in sickle cell anemia patients of Odisha, India.
    Ann Hematol. 2019 Aug 22. pii: 10.1007/s00277-019-03776.
    PubMed     Text format     Abstract available


  24. NG DB, Schiller G, Ha E
    Autoimmune hemolytic anemia in refractory hairy cell leukemia on dabrafenib and trametinib.
    Ann Hematol. 2019 Aug 13. pii: 10.1007/s00277-019-03780.
    PubMed     Text format    


  25. RAY R, Kalantri SA, Bhattacharjee S, Biswas A, et al
    Association of alpha hemoglobin-stabilizing protein (AHSP) gene mutation and disease severity among HbE-beta thalassemia patients.
    Ann Hematol. 2019;98:1827-1834.
    PubMed     Text format     Abstract available


  26. LIN X, Cheng B, Cai Y, Jiao X, et al
    Establishing and evaluating an auto-verification system of thalassemia gene detection results.
    Ann Hematol. 2019;98:1835-1844.
    PubMed     Text format     Abstract available


    July 2019
  27. SHIMIZU R, Takeuchi M, Sakaida E, Ohwada C, et al
    Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation.
    Ann Hematol. 2019;98:1781-1783.
    PubMed     Text format    


  28. NIEDEGGEN C, Singer S, Groth M, Petermann-Meyer A, et al
    Design and development of a disease-specific quality of life tool for patients with aplastic anaemia and/or paroxysmal nocturnal haemoglobinuria (QLQ-AA/PNH)-a report on phase III.
    Ann Hematol. 2019;98:1547-1559.
    PubMed     Text format     Abstract available


  29. ARMENIS I, Kalotychou V, Tzanetea R, Moyssakis I, et al
    Reduced peripheral blood superoxide dismutase 2 expression in sickle cell disease.
    Ann Hematol. 2019;98:1561-1572.
    PubMed     Text format     Abstract available


  30. VOSKARIDOU E, Ntanasis-Stathopoulos I, Christoulas D, Dimopoulou M, et al
    Activin-A is elevated in patients with thalassemia major and double heterozygous sickle cell/beta-thalassemia and correlates with markers of hemolysis and bone mineral density.
    Ann Hematol. 2019;98:1583-1592.
    PubMed     Text format     Abstract available


  31. DE LA FUENTE-GONZALO F, Nieto JM, Villegas A, Gonzalez FA, et al
    Characterization of deletional and non-deletional alpha globin variants in a large cohort from Spain between 2009 and 2014.
    Ann Hematol. 2019;98:1537-1545.
    PubMed     Text format     Abstract available


  32. SIRIVADHANAKUL P, Chuansumrit A, Songdej D, Kadegasem P, et al
    Increased endothelial activation in alpha-thalassemia disease.
    Ann Hematol. 2019;98:1593-1602.
    PubMed     Text format     Abstract available


    June 2019
  33. SU S, Liu Z, Wang F, Zhang Y, et al
    Aplastic anemia associated with Crohn's disease: a tertiary center retrospective study.
    Ann Hematol. 2019 Jun 29. pii: 10.1007/s00277-019-03729.
    PubMed     Text format     Abstract available


  34. JORGE SE, Lanaro C, Albuquerque DM, Nascimento PH, et al
    Hb Fairfax [HBB:c.285_286insGAGCTGCACTGTGAC] in a Brazilian patient with severe hemolytic anemia-identification and functional study.
    Ann Hematol. 2019 Jun 28. pii: 10.1007/s00277-019-03728.
    PubMed     Text format    


  35. SOLTERMANN Y, Heim D, Medinger M, Baldomero H, et al
    Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study.
    Ann Hematol. 2019;98:1485-1493.
    PubMed     Text format     Abstract available


  36. RICCHI P, Meloni A, Grigoratos C, Toia P, et al
    Prevalence of extramedullary hematopoiesis, renal cysts, splenic and hepatic lesions, and vertebral hemangiomas among thalassemic patients: a retrospective study from the Myocardial Iron Overload in Thalassemia (MIOT) network.
    Ann Hematol. 2019;98:1333-1339.
    PubMed     Text format     Abstract available


  37. TRAKADA G, Kastritis E, Gavriatopoulou M, Velentza L, et al
    Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcome.
    Ann Hematol. 2019;98:1427-1434.
    PubMed     Text format     Abstract available


  38. KOOHI F, Kazemi T, Miri-Moghaddam E
    Cardiac complications and iron overload in beta thalassemia major patients-a systematic review and meta-analysis.
    Ann Hematol. 2019;98:1323-1331.
    PubMed     Text format     Abstract available


    May 2019
  39. LI Y, Zhang Z, Yang L, Li X, et al
    Colla corii asini might upregulate ZNF471 and THOC5 by KRAB domain-containing zinc-finger protein pathway and THO complex subunit 5 pathway to improve anemia of pregnant women with beta-thalassemia.
    Ann Hematol. 2019 May 16. pii: 10.1007/s00277-019-03710.
    PubMed     Text format     Abstract available


  40. LEVI M, Simonetti M, Marconi E, Brignoli O, et al
    Gender differences in determinants of iron-deficiency anemia: a population-based study conducted in four European countries.
    Ann Hematol. 2019 May 9. pii: 10.1007/s00277-019-03707.
    PubMed     Text format     Abstract available


  41. CANNIZZO E, Raia M, De Propris MS, Triolo A, et al
    Features, reason for testing, and changes with time of 583 paroxysmal nocturnal hemoglobinuria clones from 529 patients: a multicenter Italian study.
    Ann Hematol. 2019;98:1083-1093.
    PubMed     Text format     Abstract available


  42. CHALOEMWONG J, Tantiworawit A, Rattanathammethee T, Chai-Adisaksopha C, et al
    Hyperuricemia, urine uric excretion, and associated complications in thalassemia patients.
    Ann Hematol. 2019;98:1101-1110.
    PubMed     Text format     Abstract available


    April 2019
  43. BAKR S, Khorshied M, Talha N, Jaffer KY, et al
    Implication of HMOX1 and CCR5 genotypes on clinical phenotype of Egyptian patients with sickle cell anemia.
    Ann Hematol. 2019 Apr 27. pii: 10.1007/s00277-019-03697.
    PubMed     Text format     Abstract available


  44. LANGER AL, Leader A, Kim-Schulze S, Ginzburg Y, et al
    Inhaled steroids associated with decreased macrophage markers in nonasthmatic individuals with sickle cell disease in a randomized trial.
    Ann Hematol. 2019;98:841-849.
    PubMed     Text format     Abstract available


  45. TAN CW, Wong WH, Idros R, Chan YH, et al
    Role of platelets in thrombin generation amongst patients with non-transfusion-dependent thalassaemia.
    Ann Hematol. 2019;98:861-868.
    PubMed     Text format     Abstract available


  46. BRANCALEONI V, Moukhadder HM, Consonni D, Koussa S, et al
    Common fetal hemoglobin variants in Lebanese patients bearing the codon 29 beta gene mutation associated with different thalassemia phenotypes.
    Ann Hematol. 2019;98:833-840.
    PubMed     Text format     Abstract available


  47. PATEL K, Bhivandkar S, Desai R, Antin T, et al
    The burden of psychiatric illnesses in adult patients with beta-thalassemia: a 5-year nationwide inpatient evaluation in the United States.
    Ann Hematol. 2019;98:851-860.
    PubMed     Text format     Abstract available


    March 2019
  48. AMES NJ, Barb JJ, Ranucci A, Kim H, et al
    The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study.
    Ann Hematol. 2019 Mar 27. pii: 10.1007/s00277-019-03599.
    PubMed     Text format     Abstract available


  49. ECSEDI M, Lengline E, Knol-Bout C, Bosman P, et al
    Use of eltrombopag in aplastic anemia in Europe.
    Ann Hematol. 2019 Mar 26. pii: 10.1007/s00277-019-03652.
    PubMed     Text format     Abstract available


  50. CHENG H, Wang X, Zhou D, Cao J, et al
    Eltrombopag combined with cyclosporine may have an effect on very severe aplastic anemia.
    Ann Hematol. 2019 Mar 20. pii: 10.1007/s00277-019-03658.
    PubMed     Text format    


  51. PAPADATOU I, Lagousi T, Kattamis A, Spoulou V, et al
    Antibody persistence 5 years after a 13-valent pneumococcal conjugate vaccine in asplenic patients with beta-thalassemia: assessing the need for booster.
    Ann Hematol. 2019;98:775-779.
    PubMed     Text format     Abstract available


  52. AL-SAWAF O, Kohler P, Eichenauer DA, Boll B, et al
    Management of an adult patient with sickle cell disease and acute chest syndrome by veno-venous extracorporeal membrane oxygenation.
    Ann Hematol. 2019;98:789-791.
    PubMed     Text format    


    February 2019
  53. ZHANG H, Wan W, Liu X, Wen C, et al
    A case report of congenital erythropoietic anemia II in China with a novel mutation.
    Ann Hematol. 2019 Feb 12. pii: 10.1007/s00277-019-03612.
    PubMed     Text format    


  54. BISWAS S, Nag A, Ghosh K, Ray R, et al
    Genetic determinants related to pharmacological induction of foetal haemoglobin in transfusion-dependent HbE-beta thalassaemia.
    Ann Hematol. 2019;98:289-299.
    PubMed     Text format     Abstract available


  55. MANAKENG K, Prasertphol P, Phongpao K, Chuncharunee S, et al
    Elevated levels of platelet- and red cell-derived extracellular vesicles in transfusion-dependent beta-thalassemia/HbE patients with pulmonary arterial hypertension.
    Ann Hematol. 2019;98:281-288.
    PubMed     Text format     Abstract available


    January 2019
  56. CHEN X, Hu J, Zhu J, Xu W, et al
    Severe hemolytic anemia due to combined alpha thalassemia and de novo Hemoglobin Sabine.
    Ann Hematol. 2019 Jan 23. pii: 10.1007/s00277-019-03617.
    PubMed     Text format    


  57. LOBITZ S, Klein J, Brose A, Blankenstein O, et al
    Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newborns.
    Ann Hematol. 2019;98:47-53.
    PubMed     Text format     Abstract available


  58. MENG LL, Yuan SM, Tu CF, Lin G, et al
    Next-generation sequencing identified a novel SPTB frameshift insertion causing hereditary spherocytosis in China.
    Ann Hematol. 2019;98:223-226.
    PubMed     Text format    


    December 2018
  59. RINELLI M, Bellacchio E, Berardinelli F, Pascolini G, et al
    Correction to: Structural modeling of a novel TERC variant in a patient with aplastic anemia and short telomeres.
    Ann Hematol. 2018 Dec 14. pii: 10.1007/s00277-018-3581.
    PubMed     Text format     Abstract available


  60. LAFARGE A, Bertinchamp R, Pichereau C, Valade S, et al
    Prognosis of autoimmune hemolytic anemia in critically ill patients.
    Ann Hematol. 2018 Dec 10. pii: 10.1007/s00277-018-3553.
    PubMed     Text format     Abstract available


  61. HOSOKAWA K, Sugimori C, Ishiyama K, Takamatsu H, et al
    Establishment of a flow cytometry assay for detecting paroxysmal nocturnal hemoglobinuria-type cells specific to patients with bone marrow failure.
    Ann Hematol. 2018;97:2289-2297.
    PubMed     Text format     Abstract available


    November 2018
  62. AKRAM Z, Ahmed P, Kajigaya S, Satti TM, et al
    Epidemiological, clinical and genetic characterization of aplastic anemia patients in Pakistan.
    Ann Hematol. 2018 Nov 13. pii: 10.1007/s00277-018-3542.
    PubMed     Text format     Abstract available


  63. LONG Z, Yu F, Du Y, Li H, et al
    Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus.
    Ann Hematol. 2018;97:2047-2054.
    PubMed     Text format     Abstract available


  64. SHALLIS RM, Xu ML, Curtis SA, Medoff E, et al
    Conviction in the face of affliction: a case series of Jehovah's Witnesses with myeloid malignancies.
    Ann Hematol. 2018;97:2245-2248.
    PubMed     Text format    


  65. OLIVEIRA CC, Rocha JTQ, Silva GF, Biglia B, et al
    Would you think of histiocytic sarcoma in this fine-needle aspiration?
    Ann Hematol. 2018;97:2257-2259.
    PubMed     Text format    


  66. GUIRAT DHOUIB N, Khaled MB, Ouederni M, Besbes H, et al
    Hypertransaminasemia revealing a clinically silent muscular dystrophy in a child with sickle cell disease.
    Ann Hematol. 2018;97:2261-2262.
    PubMed     Text format    


    October 2018
  67. YABE M, Koike T, Ohtsubo K, Imai E, et al
    Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia.
    Ann Hematol. 2018 Oct 27. pii: 10.1007/s00277-018-3517.
    PubMed     Text format     Abstract available


  68. WANG Z-, Yu H-, Cao F-, Liu Z-, et al
    Donor-derived marrow mesenchymal stromal cell co-transplantation following a haploidentical hematopoietic stem cell transplantation trail to treat severe aplastic anemia in children.
    Ann Hematol. 2018 Oct 19. pii: 10.1007/s00277-018-3523.
    PubMed     Text format     Abstract available


  69. MAKISHIMA K, Obara N, Ishitsuka K, Sukegawa S, et al
    High efficacy of eculizumab treatment for fulminant hemolytic anemia in primary cold agglutinin disease.
    Ann Hematol. 2018 Oct 15. pii: 10.1007/s00277-018-3521.
    PubMed     Text format    


  70. REN Q, Zhou YL, Wang L, Chen YS, et al
    Clinical trial on the effects of thalidomide on hemoglobin synthesis in patients with moderate thalassemia intermedia.
    Ann Hematol. 2018;97:1933-1939.
    PubMed     Text format     Abstract available


  71. HAGHPANAH S, Zarei T, Eshghi P, Zekavat O, et al
    Efficacy and safety of resveratrol, an oral hemoglobin F-augmenting agent, in patients with beta-thalassemia intermedia.
    Ann Hematol. 2018;97:1919-1924.
    PubMed     Text format     Abstract available


  72. RICCHI P, Meloni A, Pistoia L, Spasiano A, et al
    The effect of desferrioxamine chelation versus no therapy in patients with non transfusion-dependent thalassaemia: a multicenter prospective comparison from the MIOT network.
    Ann Hematol. 2018;97:1925-1932.
    PubMed     Text format     Abstract available


  73. FUJITA Y, Nakazato T, Ito C, Masuda K, et al
    A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment.
    Ann Hematol. 2018;97:2009-2010.
    PubMed     Text format    


    September 2018
  74. LI SS, Hsu YT, Chang C, Lee SC, et al
    Incidence and treatment outcome of aplastic anemia in Taiwan-real-world data from single-institute experience and a nationwide population-based database.
    Ann Hematol. 2018 Sep 3. pii: 10.1007/s00277-018-3486.
    PubMed     Text format     Abstract available


  75. SHAH S, Jain P, Shah K, Patel K, et al
    Immunosuppressive therapy for aplastic anemia: a single-center experience from western India.
    Ann Hematol. 2018 Sep 1. pii: 10.1007/s00277-018-3487.
    PubMed     Text format     Abstract available


  76. CARPIO A, Merino A, Rodriguez-Tajes S, Reverter E, et al
    Massive hemolysis complicating acute granulomatous hepatitis.
    Ann Hematol. 2018;97:1741-1742.
    PubMed     Text format    


  77. KALANTRI SA, Ray R, Chattopadhyay A, Bhattacharjee S, et al
    Efficacy of decitabine as hemoglobin F inducer in HbE/beta-thalassemia.
    Ann Hematol. 2018;97:1689-1694.
    PubMed     Text format     Abstract available


    August 2018
  78. FUREDER W, Sperr WR, Gleixner K, Thalhammer R, et al
    Major response of PNH to an AML chemotherapy protocol.
    Ann Hematol. 2018;97:1487-1488.
    PubMed     Text format    


  79. YASUNAGA M, Taoka K, Nakagawa H, Yamada A, et al
    Eculizumab treatment for ischemic enteritis accompanied with paroxysmal nocturnal hemoglobinuria: a case report and literature review.
    Ann Hematol. 2018;97:1513-1515.
    PubMed     Text format    


    July 2018
  80. YAMAMOTO A, Meguri Y, Fukuda A, Kambara Y, et al
    A case of reversible cerebral vasoconstriction syndrome developing during treatment of adult aplastic anemia.
    Ann Hematol. 2018 Jul 10. pii: 10.1007/s00277-018-3430.
    PubMed     Text format    


  81. RINELLI M, Bellacchio E, Berardinelli F, Pascolini G, et al
    Structural modeling of a novel TERC variant in a patient with aplastic anemia and short telomeres.
    Ann Hematol. 2018 Jul 6. pii: 10.1007/s00277-018-3415.
    PubMed     Text format    


  82. CLE DV, Atta EH, Dias DSP, Lima CBL, et al
    Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study.
    Ann Hematol. 2018 Jul 5. pii: 10.1007/s00277-018-3416.
    PubMed     Text format     Abstract available


    June 2018
  83. MYINT ZW, Oo TH, Thein KZ, Tun AM, et al
    Copper deficiency anemia: review article.
    Ann Hematol. 2018 Jun 29. pii: 10.1007/s00277-018-3407.
    PubMed     Text format     Abstract available


  84. ARANDA N, Bedmar C, Arija V, Jardi C, et al
    Serum hepcidin levels, iron status, and HFE gene alterations during the first year of life in healthy Spanish infants.
    Ann Hematol. 2018;97:1071-1080.
    PubMed     Text format     Abstract available


    May 2018
  85. BOHME T, Medinger M, Suenderhauf C, Speer O, et al
    Severe anemia after trans-catheter arterial chemoembolization-an unusual presentation of hemoglobin Zurich.
    Ann Hematol. 2018 May 8. pii: 10.1007/s00277-018-3353.
    PubMed     Text format    


  86. CHATTERJEE T, Chakravarty A, Chakravarty S
    Hydroxyurea responses in clinically varied beta, HbE-beta thalassaemia and sickle cell anaemia patients of Eastern India.
    Ann Hematol. 2018;97:893-898.
    PubMed     Text format     Abstract available


  87. NEMTSAS P, Arnaoutoglou M, Perifanis V, Koutsouraki E, et al
    Polyneuropathy and myopathy in beta-thalassemia major patients.
    Ann Hematol. 2018;97:899-904.
    PubMed     Text format     Abstract available


  88. RAGHUNATHAN VM, Whitesell PL, Lim SH
    Sleep-disordered breathing in patients with sickle cell disease.
    Ann Hematol. 2018;97:755-762.
    PubMed     Text format     Abstract available


    April 2018
  89. MICHALAK SS, Rupa-Matysek J, Gil L
    Comorbidities, repeated hospitalizations, and age >/= 80 years as indicators of anemia development in the older population.
    Ann Hematol. 2018 Apr 9. pii: 10.1007/s00277-018-3321.
    PubMed     Text format     Abstract available


  90. MIRLOHI MS, Yaghooti H, Shirali S, Aminasnafi A, et al
    Increased levels of advanced glycation end products positively correlate with iron overload and oxidative stress markers in patients with beta-thalassemia major.
    Ann Hematol. 2018;97:679-684.
    PubMed     Text format     Abstract available


    March 2018
  91. RODGERS GM, Gilreath JA
    Eltrombopag as initial monotherapy for severe aplastic anemia-a case report.
    Ann Hematol. 2018 Mar 20. pii: 10.1007/s00277-018-3303.
    PubMed     Text format    


    February 2018
  92. SUZUKI Y, Koya J, Ebisawa K, Abe H, et al
    Sequential development of monoclonal B cell lymphocytosis-derived small lymphocytic lymphoma and plasma cell leukemia.
    Ann Hematol. 2018 Feb 7. pii: 10.1007/s00277-018-3248.
    PubMed     Text format    


  93. GHAVAMZADEH A, Sotoudeh M, Hashemi Taheri AP, Alimoghaddam K, et al
    Liver fibrosis alleviation after co-transplantation of hematopoietic stem cells with mesenchymal stem cells in patients with thalassemia major.
    Ann Hematol. 2018;97:327-334.
    PubMed     Text format     Abstract available


    January 2018
  94. ZHAO L, Zhu H, Han B, Wang L, et al
    Influence of genetic polymorphisms of IL23R, STAT3, IL12B, and STAT4 on the risk of aplastic anemia and the effect of immunosuppressive therapy.
    Ann Hematol. 2018 Jan 12. pii: 10.1007/s00277-018-3227.
    PubMed     Text format     Abstract available


    December 2017
  95. VAN ZEVENTER IA, Schreurs JWGM, van den Berg E, Mulder AB, et al
    Efficacy of antithymocyte globulin as first-line treatment for aplastic anemia-a single-center experience.
    Ann Hematol. 2017 Dec 16. pii: 10.1007/s00277-017-3201.
    PubMed     Text format    


    November 2017
  96. SMART LR, Ambrose EE, Raphael KC, Hokororo A, et al
    Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID study.
    Ann Hematol. 2017 Nov 16. doi: 10.1007/s00277-017-3182.
    PubMed     Text format     Abstract available


  97. VISWESHWAR N, Jaglal M, Sokol L, Zuckerman K, et al
    Chemotherapy-related anemia.
    Ann Hematol. 2017 Nov 4. doi: 10.1007/s00277-017-3155.
    PubMed     Text format    


  98. FERRAO J, Silva M, Goncalves L, Gomes S, et al
    Widening the spectrum of deletions and molecular mechanisms underlying alpha-thalassemia.
    Ann Hematol. 2017;96:1921-1929.
    PubMed     Text format     Abstract available


  99. KLONIZAKIS P, Klaassen R, Sousos N, Liakos A, et al
    Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients.
    Ann Hematol. 2017;96:1937-1944.
    PubMed     Text format     Abstract available


  100. MAIRA D, Cassinerio E, Marcon A, Mancarella M, et al
    Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT).
    Ann Hematol. 2017;96:1931-1936.
    PubMed     Text format     Abstract available


    October 2017
  101. HOUSTON BL, Jayakar J, Wells RA, Lenis M, et al
    A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry.
    Ann Hematol. 2017 Oct 3. doi: 10.1007/s00277-017-3137.
    PubMed     Text format     Abstract available


  102. VILLEGAS A, Nunez R, Gaya A, Cuevas-Ruiz MV, et al
    Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria: results of a retrospective analysis from the Spanish PNH Registry.
    Ann Hematol. 2017;96:1727-1733.
    PubMed     Text format     Abstract available


    September 2017
  103. YANG N, Chen J, Zhang H, Dai Z, et al
    Horse versus rabbit antithymocyte globulin in immunosuppressive therapy of treatment-naive aplastic anemia: a systematic review and meta-analysis.
    Ann Hematol. 2017 Sep 30. doi: 10.1007/s00277-017-3136.
    PubMed     Text format     Abstract available


  104. KEDAR P, Parmar V, Devendra R, Gupta V, et al
    Congenital dyserythropoietic anemia type II mimicking hereditary spherocytosis in Indian patient with SEC23B-Y462C mutations.
    Ann Hematol. 2017 Sep 7. doi: 10.1007/s00277-017-3116.
    PubMed     Text format    


  105. GRAZIADEI G, Casoni FM, Annoni F, Cortinovis I, et al
    Transcranial color Doppler in stroke-free adult patients with sickle cell disease.
    Ann Hematol. 2017;96:1547-1555.
    PubMed     Text format     Abstract available


  106. RICCHI P, Meloni A, Costantini S, Spasiano A, et al
    Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia.
    Ann Hematol. 2017;96:1541-1546.
    PubMed     Text format     Abstract available


  107. RODEGHIERO F, Carli G
    Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.
    Ann Hematol. 2017;96:1421-1434.
    PubMed     Text format     Abstract available


    August 2017
  108. FUJIWARA T, Fukuhara N, Ichikawa S, Kobayashi M, et al
    A novel heterozygous ALAS2 mutation in a female with macrocytic sideroblastic anemia resembling myelodysplastic syndrome with ring sideroblasts: a case report and literature review.
    Ann Hematol. 2017 Aug 24. doi: 10.1007/s00277-017-3106.
    PubMed     Text format    


  109. ATTA EH, Lima CBL, Dias DSP, Cle DV, et al
    Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia.
    Ann Hematol. 2017 Aug 16. doi: 10.1007/s00277-017-3086.
    PubMed     Text format     Abstract available


  110. LI Q, Luo C, Luo C, Wang J, et al
    Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.
    Ann Hematol. 2017;96:1389-1397.
    PubMed     Text format     Abstract available


  111. WIEBKING V, Hutker S, Schmid I, Immler S, et al
    Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
    Ann Hematol. 2017;96:1373-1377.
    PubMed     Text format     Abstract available


    July 2017
  112. KLAIHMON P, Vimonpatranon S, Noulsri E, Lertthammakiat S, et al
    Normalized levels of red blood cells expressing phosphatidylserine, their microparticles, and activated platelets in young patients with beta-thalassemia following bone marrow transplantation.
    Ann Hematol. 2017 Jul 26. doi: 10.1007/s00277-017-3070.
    PubMed     Text format     Abstract available


  113. ANTUNES FD, Propheta VGS, Vasconcelos HA, Cipolotti R, et al
    Neuropathic pain in patients with sickle cell disease: a cross-sectional study assessing teens and young adults.
    Ann Hematol. 2017;96:1121-1125.
    PubMed     Text format     Abstract available


    June 2017
  114. DE LACERDA MP, Guedes NR, Yamakawa PE, Pereira AD, et al
    Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with (del17p).
    Ann Hematol. 2017 Jun 9. doi: 10.1007/s00277-017-3039.
    PubMed     Text format    


  115. OKA S, Ono K, Nohgawa M
    Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation.
    Ann Hematol. 2017 Jun 2. doi: 10.1007/s00277-017-3032.
    PubMed     Text format    


  116. TESSOULIN B, Thomare P, Delande E, Moynard J, et al
    Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomas.
    Ann Hematol. 2017;96:943-950.
    PubMed     Text format     Abstract available


  117. SURAPOLCHAI P, Chuansumrit A, Sirachainan N, Kadegasem P, et al
    A molecular study on the role of alpha-hemoglobin-stabilizing protein in hemoglobin H disease.
    Ann Hematol. 2017;96:1005-1014.
    PubMed     Text format     Abstract available


  118. BALDINI M, Marcon A, Ulivieri FM, Seghezzi S, et al
    Bone quality in beta-thalassemia intermedia: relationships with bone quantity and endocrine and hematologic variables.
    Ann Hematol. 2017;96:995-1003.
    PubMed     Text format     Abstract available


  119. CASSINERIO E, Baldini IM, Alameddine RS, Marcon A, et al
    Pregnancy in patients with thalassemia major: a cohort study and conclusions for an adequate care management approach.
    Ann Hematol. 2017;96:1015-1021.
    PubMed     Text format     Abstract available


    May 2017
  120. CASTELLI R, Sciara S, Lambertenghi Deliliers G, Pantaleo G, et al
    Biosimilar epoetin alfa increases haemoglobin levels and brings cognitive and socio-relational benefits to elderly transfusion-dependent multiple myeloma patients: results from a pilot study.
    Ann Hematol. 2017;96:779-786.
    PubMed     Text format     Abstract available


  121. LAI YK, Lai NM, Lee SW
    Glucose-6-phosphate dehydrogenase deficiency and risk of diabetes: a systematic review and meta-analysis.
    Ann Hematol. 2017;96:839-845.
    PubMed     Text format     Abstract available


    April 2017
  122. YOUSSRY I, Soliman N, Ghamrawy M, Samy RM, et al
    Circulating microparticles and the risk of thromboembolic events in Egyptian beta thalassemia patients.
    Ann Hematol. 2017;96:597-603.
    PubMed     Text format     Abstract available


  123. ALASHKAR F, Vance C, Herich-Terhurne D, Preising N, et al
    Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab.
    Ann Hematol. 2017;96:589-596.
    PubMed     Text format     Abstract available


  124. CHEN M, Zhuang J, Zhou D, Xu Y, et al
    Outcome of anti-thymocyte immunoglobulin plus cyclosporine A for severe aplastic anaemia with chronic hepatitis B virus infection.
    Ann Hematol. 2017;96:581-587.
    PubMed     Text format     Abstract available


    March 2017
  125. GREGORY GP, Farrell A, Brown S
    Cold agglutinin disease complicated by acrocyanosis and necrosis.
    Ann Hematol. 2017;96:509-510.
    PubMed     Text format    


    February 2017
  126. PUIGVI L, Baumann T, Fernandez S, Castro P, et al
    Massive erythrophagocytosis by peripheral monocytes and neutrophils in parvovirus-B19 autoimmune hemolytic anemia.
    Ann Hematol. 2017 Feb 21. doi: 10.1007/s00277-017-2957.
    PubMed     Text format    


  127. KNUPPEL E, Medinger M, Stehle G, Infanti L, et al
    Haploidentical hematopoietic bone marrow transplantation followed by living kidney transplantation from the same donor in a sickle cell disease patient with end-stage renal failure.
    Ann Hematol. 2017 Feb 3. doi: 10.1007/s00277-017-2936.
    PubMed     Text format    


  128. KLAIHMON P, Phongpao K, Kheansaard W, Noulsri E, et al
    Microparticles from splenectomized beta-thalassemia/HbE patients play roles on procoagulant activities with thrombotic potential.
    Ann Hematol. 2017;96:189-198.
    PubMed     Text format     Abstract available


  129. WANG HC, Hsieh LL, Liu YC, Hsiao HH, et al
    The epidemiologic transition of thalassemia and associated hemoglobinopathies in southern Taiwan.
    Ann Hematol. 2017;96:183-188.
    PubMed     Text format     Abstract available


  130. BURKHARDT L, Lobitz S, Koustenis E, Rueckriegel SM, et al
    Cognitive and fine motor deficits in a pediatric sickle cell disease cohort of mixed ethnic origin.
    Ann Hematol. 2017;96:199-213.
    PubMed     Text format     Abstract available


    January 2017
  131. OUEDERNI M, Ben Khaled M, Mellouli F, Ben Fraj E, et al
    Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients.
    Ann Hematol. 2017;96:133-139.
    PubMed     Text format     Abstract available


  132. BOGUSLAWSKA DM, Heger E, Machnicka B, Skulski M, et al
    A new frameshift mutation of the beta-spectrin gene associated with hereditary spherocytosis.
    Ann Hematol. 2017;96:163-165.
    PubMed     Text format    


  133. AL NAJJAR S, Adam S, Ahmed N, Qari M, et al
    Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease.
    Ann Hematol. 2017;96:141-146.
    PubMed     Text format     Abstract available


    December 2016
  134. LIANG XH, Rong L, He G, He H, et al
    Polymorphisms of the TGF-beta1 gene and the risk of acquired aplastic anemia in a Chinese population.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available


  135. OH DH, Motorna O, Kong JB, Brown S, et al
    Linezolid-associated reticulocytopenia.
    Ann Hematol. 2016;95:2095-2097.
    PubMed     Text format    


    November 2016
  136. GROTH M, Singer S, Niedeggen C, Petermann-Meyer A, et al
    Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)-report on phases I and II.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  137. ZHANG XH, Wang QM, Chen H, Chen YH, et al
    Clinical characteristics and risk factors of Intracranial hemorrhage in patients following allogeneic hematopoietic stem cell transplantation.
    Ann Hematol. 2016;95:1637-43.
    PubMed     Text format     Abstract available


  138. CRISP RL, Maltaneri RE, Vittori DC, Solari L, et al
    Red blood cell aquaporin-1 expression is decreased in hereditary spherocytosis.
    Ann Hematol. 2016;95:1595-601.
    PubMed     Text format     Abstract available


  139. PHONDEECHAREON T, Wattanapanitch M, U-Pratya Y, Damkham C, et al
    Generation of induced pluripotent stem cells as a potential source of hematopoietic stem cells for transplant in PNH patients.
    Ann Hematol. 2016;95:1617-25.
    PubMed     Text format     Abstract available


  140. URESHINO H, Miyahara M
    Unusual co-occurrence of Evans syndrome and pure red cell aplasia in elderly patient with prostate cancer.
    Ann Hematol. 2016;95:1743-4.
    PubMed     Text format    


  141. HUANG Y, Wang M, Yu C, Lei Y, et al
    Clinical presentation of the hemoglobin Youngstown variant in a Chinese family.
    Ann Hematol. 2016;95:1925-7.
    PubMed     Text format    


  142. BALAIAN E, Schuster C, Schonefeldt C, Germing U, et al
    Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5q.
    Ann Hematol. 2016;95:1805-10.
    PubMed     Text format     Abstract available


    September 2016
  143. VAGACE JM, Cardesa R, Corbacho A, Vazquez T, et al
    Etiopathological mechanisms and clinical characteristics of hyperhemolysis syndrome in Spanish patients with thalassemia.
    Ann Hematol. 2016;95:1419-27.
    PubMed     Text format     Abstract available


  144. LANZA F, Lazzari MC, Brambilla P, Di Martino G, et al
    An unusual association of paroxysmal nocturnal hemoglobinuria, myelodysplastic syndrome, and diffuse large B-cell non-Hodgkin lymphoma in a Caucasian man.
    Ann Hematol. 2016;95:1555-7.
    PubMed     Text format    


  145. HAGIWARA K, Kamesaki T, Kakimoto T, Fukushima K, et al
    Long-term follow-up of non-syphilitic paroxysmal cold hemoglobinuria in an adult.
    Ann Hematol. 2016;95:1547-9.
    PubMed     Text format    


    August 2016
  146. ZAREI T, Haghpanah S, Parand S, Moravej H, et al
    Evaluation of bone mineral density in patients with hemoglobin H disease.
    Ann Hematol. 2016;95:1329-32.
    PubMed     Text format     Abstract available


  147. KARIMI M, Haghpanah S, Pishdad P, Rachmilewitz EA, et al
    Frequency of silent cerebral ischemia in patients with transfusion-dependent beta-thalassemia major compared to healthy individuals.
    Ann Hematol. 2016;95:1387.
    PubMed     Text format    


  148. ZAFARI M, Kosaryan M, Gill P, Alipour A, et al
    Non-invasive prenatal diagnosis of beta-thalassemia by detection of the cell-free fetal DNA in maternal circulation: a systematic review and meta-analysis.
    Ann Hematol. 2016;95:1341-50.
    PubMed     Text format     Abstract available


    June 2016
  149. UPADHYE D, Jain D, Trivedi Y, Nadkarni A, et al
    Influence of single nucleotide polymorphisms in the BCL11A and HBS1L-MYB gene on the HbF levels and clinical severity of sickle cell anaemia patients.
    Ann Hematol. 2016;95:1201-3.
    PubMed     Text format    


    May 2016
  150. MUSA BM, Galadanci NA, Coker M, Bussell S, et al
    The global burden of pulmonary hypertension in sickle cell disease: a systematic review and meta-analysis.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available


  151. KARACAOGLU PK, Asma S, Korur A, Solmaz S, et al
    East Mediterranean region sickle cell disease mortality trial: retrospective multicenter cohort analysis of 735 patients.
    Ann Hematol. 2016;95:993-1000.
    PubMed     Text format     Abstract available


  152. CARLI G, Visco C, Falisi E, Perbellini O, et al
    Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome.
    Ann Hematol. 2016;95:863-70.
    PubMed     Text format     Abstract available


  153. PIERINI A, Mancusi A, Terenzi A, Massei MS, et al
    New mechanism of lymphoma-induced bone marrow aplasia.
    Ann Hematol. 2016;95:1013-5.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: